NASDAQ:VAXX

Vaxxinity Stock Insider Trading

Healthcare > Biotechnology

Buy VAXX

*Your capital is at risk

$0.0001

+0 (+0%)

At Close: Jun 03, 2026

Vaxxinity Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 8.82M and sold 1.54M VAXX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	0
● Buy	8.82M shares
● Sell	1.54M shares
62% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Nov 03, 2023 Buy	Common Stock J-Other	Paula Molina Rene Officer	Officer	0 Value: $0
Nov 03, 2023 Buy	Common Stock J-Other	Paula Molina Rene Officer	Officer	0 Value: $0
Nov 01, 2023 Buy	Employee Stock option (right to buy) A-Award	Ray Sumita Chief Legal, Comp & Admin Off	Officer	425 000 Value: $497.3K
Nov 01, 2023 Buy	Employee Stock option (right to buy) A-Award	Ray Sumita Chief Legal, Comp & Admin Off	Officer	425 000 Value: $497.3K
Oct 02, 2023 Buy	Stock option (right to buy) A-Award	Powchik Peter Director	Director	159 744 Value: $202.9K
Oct 02, 2023 Buy	Stock option (right to buy) A-Award	Powchik Peter Director	Director	159 744 Value: $202.9K
Oct 01, 2023 Buy	Common Stock J-Other	Ray Sumita Officer	Officer	0 Value: $0
Oct 01, 2023 Buy	Common Stock J-Other	Ray Sumita Officer	Officer	0 Value: $0
Sep 08, 2023 Sell	Class A common stock S-Sale	Prime Movers Lab Fund I Lp 10 Percent Owner	10% Owner	25 089 Value: $41.9K
Sep 08, 2023 Sell	Class A common stock S-Sale	Prime Movers Lab Fund I Lp 10 Percent Owner	10% Owner	10 349 Value: $17.3K
Sep 08, 2023 Sell	Class A common stock S-Sale	Prime Movers Lab Fund I Lp 10 Percent Owner	10% Owner	5 911 Value: $10K
Sep 08, 2023 Sell	Class A common stock S-Sale	Prime Movers Lab Fund I Lp 10 Percent Owner	10% Owner	4 217 Value: $7K
Sep 08, 2023 Sell	Class A Common Stock S-Sale	Prime Movers Lab Fund I Lp 10 Percent Owner	10% Owner	2 395 Value: $4K
Sep 08, 2023 Sell	Class A Common Stock S-Sale	Prime Movers Lab Fund I Lp 10 Percent Owner	10% Owner	2 395 Value: $4K
Sep 08, 2023 Sell	Class A common stock S-Sale	Prime Movers Lab Fund I Lp 10 Percent Owner	10% Owner	4 217 Value: $7K
Sep 08, 2023 Sell	Class A common stock S-Sale	Prime Movers Lab Fund I Lp 10 Percent Owner	10% Owner	5 911 Value: $10K
Sep 08, 2023 Sell	Class A common stock S-Sale	Prime Movers Lab Fund I Lp 10 Percent Owner	10% Owner	10 349 Value: $17.3K
Sep 08, 2023 Sell	Class A common stock S-Sale	Prime Movers Lab Fund I Lp 10 Percent Owner	10% Owner	25 089 Value: $41.9K
Sep 07, 2023 Sell	Class A Common Stock S-Sale	Prime Movers Lab Fund I Lp 10 Percent Owner	10% Owner	20 312 Value: $36.3K
Sep 07, 2023 Sell	Class A common stock S-Sale	Prime Movers Lab Fund I Lp 10 Percent Owner	10% Owner	8 378 Value: $15.0K
Sep 07, 2023 Sell	Class A Common Stock S-Sale	Prime Movers Lab Fund I Lp 10 Percent Owner	10% Owner	4 786 Value: $9K
Sep 07, 2023 Sell	Class A common stock S-Sale	Prime Movers Lab Fund I Lp 10 Percent Owner	10% Owner	3 413 Value: $6K
Sep 07, 2023 Sell	Class A Common Stock S-Sale	Prime Movers Lab Fund I Lp 10 Percent Owner	10% Owner	1 939 Value: $3K
Sep 07, 2023 Sell	Class A Common Stock S-Sale	Prime Movers Lab Fund I Lp 10 Percent Owner	10% Owner	1 939 Value: $3K
Sep 07, 2023 Sell	Class A common stock S-Sale	Prime Movers Lab Fund I Lp 10 Percent Owner	10% Owner	3 413 Value: $6K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT VAXXINITY, INC.

Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that targets toxic forms of aggregated a-synuclein in the brain to fight Parkinson's disease and other synu...

Read Full Profile Here